Global M&A China was founded in 1998 to deliver investment banking solutions (M&A) and fund management service in Healthcare & Consumer Products. In 18 years of activity, they successfully completed more than 220 transactions valued at more than US$ 16 billion. The company currently manage more than USD$ 700 million of asset through two pharmaceutical fund.
The team of Global M&A China consists of professionals from a variety of backgrounds and bring a world of specialized industry experience and personal insights into the businesses. They have an established track record of serving middle to large corporations including privately-held businesses and public companies. The company has developed sourcing capability that leverages both their professional networks, and Hollyhigh’s brand, reputation throughout China’s entrepreneurial community
Global M&A China trades locally as Hollyhigh International Capital, and has offices in both Beijing and Shanghai.
17F Tower A JiaTai Mansion, No.41,E.
4th Ringroad, Beijing,